human
medicin
diseas
diagnosi
veterinari
medicin
practic
import
sever
reason
includ
issu
anim
health
welfar
public
health
especi
case
zoonot
agent
affect
pet
anim
human
consumpt
economi
mainli
relat
rule
barrier
intern
trade
anim
anim
product
veterinari
field
import
consid
fauna
speci
cattl
farm
anim
mainli
larg
terrestri
livestock
anim
fish
aquacultur
well
like
pet
captiv
eg
zoo
circu
aquarium
wild
anim
constitut
underestim
sourc
mani
human
infecti
diseas
especi
viral
origin
anim
human
contamin
veterinaryrelev
pathogen
may
occur
infect
anim
live
dead
infect
anim
product
eg
bush
meat
unpasteur
milk
lesser
extent
direct
contact
pathogen
develop
countri
region
impact
livestock
diseas
outbreak
goe
far
beyond
anim
welfar
food
safeti
often
farm
anim
also
way
human
cargo
transport
also
incom
feedstock
sourc
manur
draft
power
raw
materi
industri
eg
leather
shoe
cloth
advent
human
immunodefici
viru
hiv
acquir
immunodefici
syndrom
aid
human
immun
depress
condit
rel
neglect
factor
enhanc
suscept
human
anim
diseas
especi
respect
pet
immunedepress
individu
vulner
group
children
elderli
may
even
becom
suscept
subtyp
zoonot
microorgan
usual
harmless
healthi
human
interact
domest
wild
anim
may
also
provid
import
via
indirect
human
contamin
particularli
import
group
zoonot
agent
enter
pathogen
transmit
human
anim
oralfec
rout
subsequ
dissemin
wastewat
effluent
outbreak
may
occur
upon
contamin
surfac
water
groundwat
use
recreat
irrig
purpos
insuffici
microbi
remov
drink
water
andor
treat
wastewat
sinc
mani
enter
pathogen
resili
classic
treatment
disinfect
procedur
often
contamin
water
suppli
small
concentr
henc
hinder
final
disinfect
complic
detect
well
screen
enter
zoonot
agent
propos
pet
cohabit
immunesuscept
human
often
presenc
enter
virus
detect
indirectli
bacteri
indic
fecal
contamin
name
coliform
enterococci
hand
emerg
wildtyp
zoonosi
transmit
anim
human
eg
sar
west
nile
viru
specif
mutat
facilit
speci
jump
eg
hiv
influenza
concern
bioterror
issu
depend
natur
infecti
pathogen
detect
potenti
zoonot
agent
anim
alert
intent
releas
act
success
antibioterror
strategi
must
account
detect
known
pathogen
also
genet
modifi
form
howev
potenti
veterinari
pathogen
fulfil
criteria
consid
effect
bioterrorist
agent
group
compos
viral
agent
rinderpest
classic
swine
fever
african
swine
fever
avian
influenza
newcastl
diseas
rift
valley
fever
footandmouth
diseas
fmd
among
fmd
avian
influenza
especi
import
high
preval
world
zoonot
potenti
ramp
spread
fmd
gener
consid
contagi
viral
diseas
anim
occasion
occurr
nonendem
region
usual
difficult
expens
control
avian
influenza
viral
diseas
pandem
potenti
pig
act
intermedi
host
influenza
virus
bird
human
bidirect
transmiss
virus
human
pig
document
diagnosi
airborn
diseas
challeng
implic
diseas
control
especi
case
outbreak
individu
case
manag
diseas
time
adopt
quarantin
measur
massiv
antimicrobi
therapi
administr
may
suffici
contain
emerg
outbreak
long
first
case
spot
short
time
howev
may
impractic
develop
countri
region
effect
routin
surveil
flaw
thu
success
contain
strategi
must
includ
rapid
diagnosi
inexpens
easytous
portabl
devic
inthefield
use
exampl
propos
within
h
report
suspici
fmd
case
definit
detect
made
upon
sampl
transport
nation
region
laboratori
els
farm
within
h
report
definit
identif
infect
strainsubtyp
accomplish
immedi
follow
vaccin
product
store
antigen
distribut
follow
trend
human
medicin
diagnosi
anim
diseas
also
undergon
progress
decentr
central
refer
laboratori
inthefield
bioanalyt
instrument
often
resourcedeplet
region
set
even
outsid
laboratori
infrastructur
essenti
done
adapt
convent
analyt
method
instrument
portabl
autom
devic
abl
handl
laboratori
unskil
personnel
viz
veterinarian
practition
farmer
sever
nomenclatur
given
test
includ
name
field
test
rapid
test
biosensor
pointofcar
poc
test
last
term
predominantli
use
throughout
chapter
improv
diagnost
test
necessari
asymptomat
diseas
diseas
mislead
symptom
diseas
requir
differ
treatment
diseas
complex
costli
treatment
requir
previou
case
confirm
contrast
test
like
littl
impact
diseas
easili
recogn
clinic
symptom
syndrom
treatmentapproach
recommend
thu
clinic
need
identifi
causal
agent
howev
surveil
control
measur
must
maintain
diseas
order
deal
risk
major
epidem
among
livestock
anim
diseas
epidem
outbreak
like
occur
higher
magnitud
given
physic
proxim
mani
anim
intens
husbandri
probabl
pathogen
contamin
neighbor
farm
rel
poor
biosecur
condit
farm
also
case
subclin
diseas
time
crucial
manag
earli
stage
infecti
diseas
immedi
preliminari
posit
result
obtain
poc
test
strongli
argu
favor
precautionari
prevent
measur
affect
farm
surround
order
avoid
transmiss
definit
accur
result
obtain
refer
laboratori
ideal
poc
test
go
toward
increas
sensit
earli
case
identif
also
diseas
surveil
epidemiolog
purpos
infect
anim
may
suffer
constitut
infect
reservoir
diseas
spread
fmd
outbreak
unit
kingdom
livestock
infect
neighbor
farm
target
cull
first
h
base
sole
clinic
sign
may
consider
doubt
especi
sheep
main
speci
affect
time
span
anim
infect
onset
clinic
symptom
henc
infect
awar
take
month
usual
rapid
silent
spread
within
herd
might
need
destroy
howev
indoor
control
studi
experiment
infect
cattl
fmd
viru
fmdv
show
smallerthanexpect
transmiss
fraction
overlap
period
incub
infecti
period
suggest
import
common
prevent
measur
taken
endang
farm
viz
preemptiv
cull
cattl
often
sever
econom
downturn
overestim
viral
diseas
sinc
onset
detect
viremia
usual
occur
least
day
onset
infect
andor
present
clinic
sign
effort
devot
develop
new
diagnosi
methodolog
tool
preclin
stage
histor
public
fund
use
compens
farmer
massiv
slaughter
suspect
diseas
anim
argu
may
gener
permiss
behavior
disinterest
livestock
industri
owner
transboundari
control
cattl
diseas
theori
poc
test
advantag
laboratorybas
test
use
detect
infect
anim
becom
infecti
especi
time
window
short
case
fmd
advantag
would
appli
time
collect
sampl
receipt
result
laboratori
least
h
medium
term
poc
test
cattl
diseas
like
play
increas
role
screen
triag
biolog
sampl
collect
farm
primari
support
decisionmak
diseas
outbreak
challeng
context
permiss
biolog
contain
veterinari
medicin
poc
test
larg
use
decad
screen
physiolog
metabolit
blood
urin
pathogen
detect
newer
applic
mainli
driven
increas
number
emerg
outbreak
includ
public
health
import
among
instanc
potenti
pandem
avian
influenza
well
influenza
virus
put
porcin
origin
human
pandem
strain
poc
test
also
develop
import
diseas
aquat
anim
use
similar
technolog
use
terrestri
anim
common
layout
commerci
avail
devic
reli
antigen
detect
biolog
sampl
affin
bind
reaction
immobil
specif
antibodi
probe
nevertheless
despit
requir
essenti
perform
featur
regulatori
approv
introduct
devic
market
understand
easier
veterinari
clinic
practic
diseas
subnotif
remain
major
problem
veterinarian
health
author
despit
notifi
diseas
obligatori
report
often
farmer
even
veterinarian
diagnost
laboratori
ignor
delay
notif
process
owe
unawar
minim
perceiv
lack
consequ
may
aggrav
econom
loss
anticip
expect
scenario
worsen
poc
test
becom
readili
avail
util
farmer
especi
case
delay
mislead
diagnosi
base
upon
clinic
sign
result
diseas
underestim
confus
sign
nonnotifi
endem
diseas
cours
interpret
clinic
sign
subsequ
decisionmak
process
compromis
fact
farmer
unskil
personnel
health
veterinari
medicin
issu
reduc
risk
nonreport
depend
tight
cooper
trust
veterinari
author
livestock
farmer
dealer
livestock
busi
especi
import
livestock
diseas
eg
classic
swine
fever
risk
announc
falseposit
result
particularli
worrisom
carri
detriment
consequ
trade
export
sanitari
requisit
import
livestock
human
feed
demand
restrict
countri
lead
sever
econom
loss
case
insuffici
inaccur
pathogen
test
therefor
individu
anim
test
may
one
main
driver
commerci
develop
poc
test
preliminari
posit
result
poc
test
may
prevent
expens
test
hold
herd
inelig
export
well
anim
diseas
particularli
contagi
abl
spread
rapidli
mani
consid
transboundari
diseas
mean
detect
turn
prohibit
livestock
export
thu
econom
loss
combin
perman
surveil
program
improv
techniqu
rapid
detect
emerg
pathogen
subtyp
effici
control
transboundari
diseas
claim
unambigu
identif
circul
pathogen
subtyp
viz
genotyp
andor
serotyp
frequent
relev
epidemiolog
featur
success
diseas
control
program
lowpreval
diseas
proport
falseposit
result
usual
higher
preval
one
addit
mani
current
poc
test
less
sensit
specif
laboratorybas
method
altogeth
mean
order
achiev
desir
level
perform
confid
result
sampl
larg
number
anim
usual
requir
pocbas
test
lowpreval
diseas
pet
preval
mani
pathogen
particularli
zoonot
parasit
probabl
underestim
consequ
among
reason
use
inadequ
inaccur
diagnost
test
procedur
includ
limit
sampl
collect
process
may
directli
result
falseneg
result
put
anim
owner
greater
risk
current
assum
intellectu
properti
constraint
frequent
hamper
passag
new
devic
proof
principl
prototyp
even
commerci
level
anoth
bottleneck
high
cost
final
develop
devic
reason
partnership
research
laboratori
biotechnolog
compani
usual
establish
purpos
case
cours
econom
leitmotiv
much
higher
highimpact
diseas
especi
control
outbreak
difficult
expens
howev
even
diseas
eg
fmd
sporad
unpredict
charact
outbreak
might
disincent
invest
individu
test
high
demand
usual
occur
occas
outbreak
suspect
outbreak
test
econom
import
livestock
diseas
develop
commerci
develop
countri
due
limit
market
result
infrequ
diseas
seem
promis
commerci
segment
poc
devic
veterinari
pathogen
concern
multiplex
platform
wide
rang
endem
nonendem
pathogen
take
advantag
rel
simplic
low
cost
incorpor
sever
addit
target
multiplex
test
inde
veterinari
health
servic
eagerli
lack
rapid
simpl
diagnost
devic
design
inthefield
simultan
detect
singl
sampl
broader
rang
common
pathogen
thu
enabl
rapid
gather
field
inform
individu
anim
whole
herd
diseas
statu
current
simultan
identif
eventu
subtyp
mani
pathogen
singl
test
run
provinc
central
refer
laboratori
avail
demand
entiti
eg
person
laboratori
agenc
abl
afford
pay
expens
test
poc
test
also
use
field
differenti
vaccin
field
strain
especi
endem
region
vaccin
permit
suitabl
applic
differenti
test
slaughter
set
confirm
prior
livestock
vaccin
argu
ultim
goal
use
poc
portabl
devic
unskil
unsupervis
practition
like
pose
enorm
challeng
overal
bioanalyt
process
sampl
acquisit
postanalyt
data
storag
interpret
manag
bear
mind
devic
commonli
use
remot
lowresourc
region
uncontrol
irregular
report
result
addit
test
biosafeti
especi
deal
zoonot
agent
major
issu
reason
balanc
merg
inthefield
test
remot
data
analysi
interpret
compet
clinic
staff
may
desir
regard
telemedicin
attract
system
healthcar
improv
develop
countri
allow
unskil
person
provid
use
healthcar
remot
set
carri
use
miniatur
analyt
devic
integr
hardwar
imag
acquisit
softwar
storag
result
result
download
hard
copi
directli
transfer
onlin
remot
healthcar
central
unit
process
interpret
expert
person
process
result
afterward
return
tester
almost
real
time
remot
data
poc
system
still
incorpor
nation
diseas
surveil
diagnost
system
threat
agent
detect
respons
tadr
develop
biolog
threat
reduct
program
btrp
us
defens
depart
defens
threat
reduct
agenc
system
use
realtim
polymerasechain
reaction
rpcr
detect
pathogen
anoth
surveil
system
electron
infecti
diseas
surveil
system
eidss
contain
subsystem
report
suspici
diseas
outbreak
real
time
eidss
abl
locat
diseas
outbreak
geograph
posit
devic
system
aim
encompass
avail
public
anim
diseas
surveil
inform
eidss
abl
report
laboratori
result
rpcr
hour
depend
distanc
system
eventu
enabl
shift
paradigm
remot
analysi
allow
world
refer
laboratori
simpli
handl
manag
diagnost
inform
pathogen
host
base
biolog
sampl
remot
collect
analyz
subsequ
report
result
countri
region
origin
full
evalu
program
poc
test
must
includ
perform
evalu
valid
qualiti
assess
control
assur
standard
perform
poc
test
highli
depend
local
condit
use
epidemiolog
pathogen
biolog
host
thu
evalu
test
set
particular
rang
inthefield
condit
use
ideal
multicent
evalu
qualiti
control
assur
correct
function
devic
prolong
use
usual
randomli
select
unit
given
product
batch
compar
infer
reproduc
qualiti
assur
step
demonstr
readi
test
introduc
routin
diagnost
practic
standard
need
poc
diagnost
veterinari
applic
well
new
rule
compar
result
obtain
two
differ
poc
laboratorybas
method
implic
final
accept
diagnost
result
proper
valid
standard
mani
poc
test
frequent
lack
part
often
correspond
inhous
rather
wellstandard
assay
techniqu
thu
import
nation
refer
healthcar
entiti
establish
qualiti
assur
program
guarante
product
refer
materi
protocol
effect
qualiti
control
rapid
diagnost
test
clinic
set
guidelin
standard
poc
bloodbas
test
alreadi
establish
hope
futur
also
use
inspir
standard
procedur
new
diagnost
veterinari
medicin
practic
poc
test
hold
great
promis
shift
paradigm
veterinari
diagnost
particularli
field
situat
case
biolog
sampl
easi
collect
process
howev
advantag
use
presum
avail
suffici
manpow
survey
enough
anim
highrisk
premis
remain
burdensom
challeng
decis
whether
use
manag
anim
infecti
diseas
depend
biolog
epidemiolog
factor
specif
circumst
clinic
sign
aris
costbenefit
issu
take
account
cost
deploy
includ
equip
reagent
storag
rel
perform
compar
diagnost
test
refer
laboratori
possibl
send
suspect
sampl
central
laboratori
within
h
probabl
discourag
use
poc
test
past
situat
western
countri
eg
medic
suspicion
highli
pathogen
avian
influenza
hpai
anoth
point
view
strengthen
idea
promis
use
test
remot
region
far
away
laboratori
set
poc
test
equival
analyt
sensit
specif
laboratorybas
test
may
foreseen
basi
poc
test
alon
take
action
beyond
simpl
restrictionquarantin
suspect
premis
transboundari
livestock
diseas
probabl
among
major
concern
veterinari
medicin
propos
effici
government
control
strategi
diseas
includ
legisl
enforc
name
diseas
screen
peopl
convey
good
arriv
countri
reason
extent
accord
previous
defin
perform
benchmark
includ
possibl
use
robot
autom
devic
b
higher
extent
screen
peopl
convey
good
arriv
endem
countri
even
reach
exhaust
screen
countri
recogn
make
accept
progress
diseas
control
c
need
develop
test
certif
anim
product
region
countri
origin
point
import
point
certainli
constitut
immens
valuabl
fountainhead
opportun
commerci
attractiondriven
develop
new
poc
devic
veterinari
field
earli
diseas
diagnosi
prevent
minim
potenti
anim
suffer
also
risk
infect
transmiss
among
suscept
host
contrast
delay
diagnosi
carri
increas
risk
sever
symptom
complic
ultim
lead
longer
suffer
increas
toxic
due
accumul
pathogen
load
andor
virul
effect
higher
risk
acquisit
drug
resist
antibodybas
detect
requir
suffici
level
antibodi
produc
success
detect
usual
happen
day
exposur
pathogen
regard
specif
detect
pathogen
nucleic
acid
biolog
sampl
pcrbase
method
may
suitabl
sinc
pathogen
genom
materi
present
host
begin
infect
even
littl
amount
detect
onset
immun
respons
marker
clinic
veterinari
sign
moreov
method
base
nucleicacid
detect
abl
detect
live
dead
pathogen
advantag
diseas
diagnosi
especi
time
crucial
diseas
contain
control
convent
method
eg
cell
cultur
serolog
pathogen
detect
strongli
depend
sampl
qualiti
lead
easili
falseneg
irreproduc
result
deoxyribonucl
acid
dna
particularli
suitabl
materi
biosens
owe
uniqu
characterist
includ
abil
highli
specif
mutual
recognit
short
immobil
oligonucleotid
probe
longers
genom
high
physicochem
stabil
unlik
enzym
antibodi
dna
form
biolog
recognit
layer
easili
synthesiz
readili
reusabl
thermal
heat
dna
also
prone
specif
manipul
process
precis
ligas
nucleas
enzym
easili
copyabl
biomolecul
pcr
similar
techniqu
amplif
also
enorm
advantag
develop
portabl
miniatur
diagnost
devic
addit
dna
micro
nanoarray
suitabl
protein
counterpart
direct
synthesi
onto
chip
surfac
without
need
produc
purifi
ligand
featur
dna
also
extens
ribonucl
acid
rna
inde
nucleicacid
molecular
biolog
test
compris
genet
analysi
dna
level
function
genom
includ
mrna
noncod
rna
microrna
particular
function
genom
dedic
identif
analysi
specif
rna
express
pattern
profil
associ
particular
experiment
clinic
condit
dna
rna
microarray
quantit
pcr
common
techniqu
use
purpos
dna
microarray
dna
chip
usual
produc
form
highli
dens
array
print
silicon
glass
chip
coat
differ
probe
simultan
detect
multipl
dnatarget
sequenc
current
microarray
detect
order
nucleicacid
sequenc
singl
chip
virochip
particularli
well
succeed
regard
panvir
dna
microarray
platform
abl
detect
known
virus
new
virus
relat
known
viral
famili
singl
assay
high
robust
confirm
virus
high
genet
variabl
swine
viru
platform
especi
use
detect
virus
avail
revers
transcriptionpcr
rtpcr
assay
nevertheless
microarray
seem
promis
poc
use
expens
complex
bulki
anoth
peculiar
dnabas
detect
superior
abil
differenti
strain
organ
especi
isol
differ
geograph
locat
use
pathogen
identif
also
epidemiolog
studi
exampl
signific
differ
among
nucleicacid
sequenc
differ
serotyp
fmdv
virus
likelihood
occurr
type
error
viral
rna
replic
demonstr
viru
rapidli
evolv
natur
constitut
enorm
challeng
success
viral
identif
influenza
virus
genet
reassort
abl
gener
novel
subtyp
whose
cell
surfac
antigen
might
longer
recogn
preexist
antibodi
antigen
drift
potenti
pandem
caus
novel
highli
pathogen
subtyp
strongli
stress
need
specif
subtyp
identif
nucleicacid
test
cours
drift
influenza
virus
respons
sudden
onset
domin
subtyp
yearli
season
requir
rapid
develop
valid
suitabl
molecular
probe
nucleicacid
test
also
unobstruct
use
test
unravel
pathogen
subtyp
circul
given
region
may
assist
design
tailor
vaccin
diseas
contain
strategi
well
track
outbreak
sourc
current
poc
test
human
anim
medicin
still
reli
antigenantibodi
bioaffin
reaction
usual
handicap
rel
small
sensit
thu
trend
shift
toward
sensit
nucleicacid
detect
usual
base
dnadna
hybrid
scheme
major
challeng
detect
pathogen
nucleic
acid
host
bodi
fluid
apart
scarciti
compar
antigen
protein
confin
insid
pathogen
cell
surround
hard
biomembran
cell
wall
consequ
nucleicacid
level
present
host
fluid
may
low
success
diagnosi
without
prior
target
amplif
pcrbase
techniqu
blood
infect
human
amount
human
genom
dna
time
higher
pathogen
dna
import
challeng
term
sensit
select
poc
test
constitut
challeng
miniatur
blood
sampl
prepar
step
especi
case
gramposit
bacteria
whose
cell
wall
thicker
rigid
gramneg
bacteria
major
avail
poc
system
clinic
veterinari
applic
requir
offdevic
sampl
prepar
includ
microorgan
concentr
nucleicacid
extract
tradit
cumbersom
timeconsum
step
especi
inthefield
test
newer
process
includ
filter
paper
captur
nucleic
acid
autom
extract
procedur
kit
develop
simplifi
task
parallel
poc
devic
develop
consider
effort
spent
simplif
robust
sampl
prepar
order
minim
manual
handl
thu
reduc
crosscontamin
effect
potenti
interf
substanc
present
nucleicacid
amplif
assay
note
technic
difficulti
inher
analysi
matric
fece
semen
decompos
tissu
detect
mycobacterium
tuberculosi
saliva
case
necessari
incorpor
poc
devic
system
abl
suppress
interf
substanc
reduc
handl
prior
nucleicacid
amplif
step
pcr
far
wide
employ
techniqu
nucleicacid
amplif
laboratori
analysi
also
poc
test
mani
similar
techniqu
origin
basic
pcr
principl
includ
nucleicacid
sequencebas
amplif
nasba
target
direct
rna
amplif
thu
preclud
need
previou
reversetranscript
step
develop
panopli
techniqu
pathogen
detect
possibl
due
increas
avail
whole
genom
sequenc
remark
case
veterinari
scienc
current
possibl
rapidli
distinguish
sever
acut
respiratori
syndrom
sar
circul
coronavirus
nevertheless
pcr
prone
falseposit
result
result
unwant
amplif
contamin
nucleic
acid
proper
qualiti
manag
issu
requir
use
adequ
control
stage
test
process
rna
analysi
rtpcr
store
biolog
sampl
low
temperatur
crucial
owe
high
liabil
rna
genom
innov
lyophil
reagent
enhanc
sensit
significantli
improv
oper
condit
poc
diseas
diagnosi
moreov
need
improv
stabil
rna
use
intern
posit
control
especi
realtim
rtpcr
assay
led
search
new
rna
sourc
anoth
approach
improv
rna
assay
use
minor
groovebind
probe
short
size
suitabl
multiplex
target
sequenc
highli
variabl
genom
nevertheless
pcrbase
techniqu
remain
challeng
poc
pathogen
diagnosi
mani
endem
region
world
even
human
medicin
howev
rtpcr
instanc
use
clinic
import
specimen
due
complex
time
demand
techniqu
linearaftertheexponenti
pcr
latepcr
anoth
pcrbase
techniqu
detect
rna
probabl
known
applic
fmdv
subtyp
tackl
difficulti
target
field
strain
novel
sequenc
mutat
even
target
sequenc
degener
primer
use
amplif
process
begin
singl
dna
molecul
abundantli
gener
amplifi
product
broad
temperatur
rang
techniqu
employ
primer
hybrid
conserv
genom
region
mismatchtoler
probe
abl
target
differ
variabl
sequenc
depend
temperatur
thu
techniqu
especi
conveni
detect
rna
virus
among
vast
divers
avail
nucleicacid
amplif
scheme
devic
proofofconcept
commerci
level
techniqu
loopmedi
isotherm
amplif
lamp
alreadi
wide
use
laboratori
analysi
seem
quit
promis
applic
poc
system
pathogen
detect
identif
remot
pcrbase
nucleicacid
test
power
suppli
keyston
devic
oper
although
use
recharg
batteri
expect
circumv
problem
avoid
need
extern
power
sourc
advantag
lamp
requir
thermal
cycl
amplif
rather
make
use
simpler
power
sourc
compar
pcr
thermocycl
oper
constant
low
temperatur
permit
lamp
incorpor
polymerbas
microdevic
instead
tradit
expens
materi
like
glass
silicon
temperatureresist
requir
pcrbase
devic
unlik
pcr
lamp
requir
denatur
templat
amplif
given
usual
abund
gener
dna
amplifi
product
often
visual
directli
viral
detect
particular
techniqu
shown
sensit
least
equival
pcr
even
rpcr
coupl
easier
sampl
prepar
procedur
featur
make
lamp
inher
simpl
henc
especi
suitabl
poc
applic
poc
test
base
nucleicacid
amplif
potenti
allow
earli
detect
latent
infect
anim
target
highrisk
premis
exampl
alreadi
appli
field
situat
howev
would
requir
sampl
collect
test
mani
suspect
herd
requir
demand
manpow
cours
outbreak
probabl
exist
test
adopt
conting
plan
mani
countri
although
issu
remain
controversi
fmd
outbreak
sampl
analyz
day
larger
outbreak
would
requir
higherthroughput
test
cours
certain
point
admiss
central
laboratori
would
becom
overload
true
poc
devic
abl
manipul
farmer
would
probabl
best
even
uniqu
solut
howev
reason
point
still
far
realiti
although
unstopp
technolog
advanc
field
coupl
new
paradigm
decentr
detect
shorten
present
distanc
goal
bioanalysi
prototyp
biosensor
poc
devic
three
main
type
signal
transduct
mechan
use
electrochem
optic
microgravimetr
mass
sensit
well
known
extens
use
research
laboratori
analyt
chemistri
hold
great
promis
new
prototyp
fulli
develop
bioanalyt
diagnost
microdevic
among
microgravimetr
method
quartzcryst
microbal
qcm
common
usual
reli
use
piezoelectr
crystal
whose
fundament
reson
frequenc
chang
upon
success
immobil
biorecognit
probe
target
howev
difficulti
miniatur
high
cost
complex
influenc
multipl
interfaci
paramet
sensor
respons
especi
liquid
phase
hamper
wider
develop
poc
devic
base
techniqu
applic
electrochem
method
nucleicacid
analysi
greatli
benefit
emerg
solid
electrod
electrochemicalbas
analyt
devic
rel
simpl
rapid
less
costli
lowpow
demand
amen
miniatur
mass
product
standard
microfabr
techniqu
optic
detect
wide
employ
transduc
principl
biosens
partial
driven
unend
advanc
optic
applic
telecommun
inform
system
furthermor
high
frequenc
optic
signal
appropri
enorm
amount
inform
carri
optic
system
devic
convent
optic
microscopi
reliabl
use
detect
imag
infecti
pathogen
cellular
molecular
level
integr
research
develop
new
poc
diagnost
devic
within
optic
detect
method
chemiluminesc
fluoresc
wide
use
versatil
design
applic
imag
method
usual
requir
bulki
expens
microscop
cameraequip
microscopi
system
ie
offdevic
format
equip
obvious
unsuit
poc
diagnost
innov
techniqu
optofluid
seem
thu
promis
regard
highthroughput
highresolut
ondevic
techniqu
make
use
compon
optofluid
devic
sampl
flow
metal
filmetch
array
submicron
apertur
imag
onto
plastic
platform
intrins
limit
convent
optic
detect
interfer
close
space
light
wave
understand
especi
limit
design
perform
miniatur
devic
multianalyt
detect
identif
howev
optic
transmiss
minuscul
structur
gain
new
impuls
techniqu
surfac
plasmon
reson
spr
light
wave
direct
interfac
metal
dielectr
techniqu
labelfre
immobil
probe
easili
reus
although
sensit
must
still
improv
moreov
face
challeng
optic
techniqu
poc
diagnosi
name
high
cost
instrument
complex
expens
optic
compon
difficulti
miniaturizationport
mass
product
advent
integr
photodiod
detector
promis
develop
cheap
sensit
easytous
easytofabr
fluorescencebas
diagnost
microdevic
remark
mileston
might
shift
current
fluorescentbas
detect
method
nakedey
visual
recognit
would
consider
reduc
complex
cost
readout
record
digit
imag
transmit
remot
clinician
trivial
inexpens
telecommun
devic
eg
digit
camera
scanner
current
exampl
includ
detect
glucos
ph
protein
expect
futur
poc
diagnost
devic
becom
connect
wireless
commun
inform
system
cameraequip
mobil
phone
network
coupl
web
databas
diagnost
imag
telemedicin
especi
remot
resourcelimit
region
set
remot
monitor
constitut
valuabl
even
indispens
way
analysi
inthefield
condit
allow
also
approach
improv
qualiti
manag
test
conduct
field
multiplex
pcr
dna
microarray
among
commonli
use
techniqu
detect
identif
infecti
pathogen
multiplex
pcr
frequent
limit
analysi
target
gene
owe
interfer
differ
primer
set
reaction
vessel
dna
microarray
usual
expens
labor
intens
complex
poc
applic
moreov
microarray
assay
usual
lengthi
due
slow
diffusionlimit
hybrid
kinet
hand
lateralflow
devic
employ
poc
diagnosi
usual
rel
low
sensit
moreov
common
format
immunochromatograph
format
correspond
wellknown
test
strip
provid
genet
inform
thu
hinder
assess
eventu
pathogen
subtyp
andor
drug
resist
marker
gener
number
target
simultan
probe
lateralflow
assay
low
thu
increas
cost
per
assay
limit
throughput
also
degre
multiplex
usual
reach
microarray
last
decad
wit
tremend
advanc
microfluid
scienc
applic
bioanalysi
microfluid
devic
basic
consist
set
microchamb
interconnect
microchannel
imprint
onto
suitabl
solid
platform
inject
system
liquid
biolog
sampl
flow
throughout
hydrophil
inner
wall
chamber
channel
final
analysi
flow
usual
control
automat
mechan
valv
primari
advantag
microfluid
develop
miniatur
diagnost
devic
especi
poc
usag
requir
small
sampl
volum
permit
save
reagent
viz
probe
label
also
gain
time
sensit
consequ
enhanc
bind
kinet
unlik
bulki
reaction
media
also
provid
lower
power
consumpt
lower
oper
cost
moreov
sinc
overal
analyt
process
autom
sampl
loss
contamin
due
human
handl
minim
parallel
improv
multiplex
capabl
confin
autom
process
also
reduc
error
due
human
manipul
increas
biosafeti
microfluid
devic
occurr
nucleicacid
hybrid
solut
enhanc
aqueou
mix
allow
surpass
kinet
barrier
slow
affin
reaction
due
limit
diffus
tradit
microarray
recent
develop
microfluid
technolog
point
toward
integr
tradit
offchip
process
microdevic
inde
signific
reduct
bulki
complex
expens
equip
mandatori
poc
inthefield
diagnost
applic
tradit
microfluid
devic
usual
reli
pressuredriven
flow
syring
pump
pressur
injector
electroosmot
flow
techniqu
requir
extern
bulki
complex
equip
like
power
suppli
poc
applic
suitabl
method
fluid
deliveri
develop
name
mechan
pump
capillar
lightdriven
motion
compar
convent
inject
system
flowinject
analysi
fia
microfluid
enabl
achiev
lower
detect
limit
result
enhanc
probetarget
bind
kinet
timedepend
target
preconcentr
microchamb
dropletbas
scheme
offer
signific
improv
microfluid
due
abil
independ
control
free
droplet
contain
target
analysi
way
singl
droplet
function
pump
valv
mixer
solidphas
extractor
thermocycl
thu
greatli
simplifi
assay
design
first
microfluid
devic
manufactur
glass
silicon
platform
high
cost
materi
led
widespread
use
polydimethylsiloxan
pdm
purpos
howev
properti
pdm
limit
use
biosens
microfluid
devic
eg
hydrophob
swellingdisintegr
organ
solvent
order
prevent
limit
pdm
materi
use
like
paper
thermoplast
materi
well
fabric
process
cheaper
pdm
glass
silicon
make
largescal
fabric
feasibl
low
cost
also
encourag
dispos
import
biosafeti
asset
deal
infecti
agent
way
avoid
crosscontamin
biolog
sampl
moreov
materi
lightweight
henc
easi
transport
form
portabl
devic
final
fabric
requir
cleanroom
set
thermoplast
attract
materi
simpl
lowcost
reproduc
fabric
poc
devic
wellknown
replic
mold
techniqu
eg
inject
mold
hot
emboss
exampl
poli
methyl
methacryl
pmma
mechan
stabl
optic
transpar
easili
modifi
surfac
anoth
exampl
polycarbon
whose
lower
thermic
conduct
comparison
glass
silicon
turn
amen
hightemperatur
pcr
applic
pattern
paperbas
microfluid
devic
valuabl
altern
test
strip
advantag
paper
includ
abund
easi
use
eg
clean
room
complex
expens
infrastructur
manipul
unnecessari
low
cost
dispos
easili
pattern
polym
molecul
convent
print
techniqu
eg
photolithographi
wax
inkjet
print
common
white
color
particularli
suitabl
use
color
substrat
quantit
colorimetr
test
moreov
unlik
test
strip
convent
microfluid
porou
natur
allow
capillaritydriven
fluid
wick
flow
structur
without
need
extern
pump
pressur
sourc
new
threedimension
structur
enabl
vertic
flow
ad
sole
later
flow
twodimension
devic
higher
complex
structur
present
plastic
frame
way
may
exhibit
improv
abil
initi
purif
concentr
liquid
wick
throughout
inner
layer
devic
final
detect
mani
current
microfluid
devic
still
reli
complex
bulki
laboratori
offchip
equip
fluid
deliveri
control
make
use
impract
field
situat
eg
emerg
respons
team
drawback
face
microfluid
system
includ
biomolecul
adsorpt
microchannel
wall
inaccur
control
temperatur
liquid
evapor
due
heatgener
compon
bubbl
format
addit
futur
develop
microfluid
platform
may
eventu
benefit
materi
improv
analyt
perform
well
simplic
costeffect
process
sampl
purif
preconcentr
usual
complex
cumbersom
biolog
analysi
molecular
diagnost
particularli
true
nucleicacid
isol
procedur
still
remain
complex
inthefield
use
one
commonest
requir
centrifug
obvious
hinder
integr
detect
scheme
within
miniatur
analyt
devic
mani
diagnost
microdevic
procedur
carri
offchip
prior
detect
step
moreov
strongli
depend
characterist
specif
biolog
sampl
requir
rel
high
volum
raw
sampl
downstream
nucleicacid
amplif
last
year
labonachip
devic
emerg
secondgener
chip
essenti
base
concept
microfluid
suitabl
integr
modul
sampl
process
analysi
singl
devic
offer
enhanc
flexibl
discriminatori
abil
convent
diagnost
method
devic
yet
minim
miniatur
whole
sampl
prepar
procedur
toward
easi
use
true
poc
remain
challeng
rel
underestim
task
develop
poc
test
compar
convent
detect
techniqu
labonachip
devic
allow
integr
autom
nearli
step
sampl
process
analysi
confin
bioelement
measur
predefin
region
interest
facilit
detect
eventu
quantif
small
sampl
volum
turn
reduc
background
nois
henc
increas
sensit
labonachip
devic
minim
chemic
interfer
result
tight
spatial
confin
usual
envisag
enabl
miniatur
highli
sensit
detect
high
mass
transfer
rate
thu
achiev
due
low
diffusion
distanc
high
surfacetovolum
ratio
sv
tradit
cell
analysi
process
includ
cell
sort
cellserum
separ
immunoassay
cell
lysi
immunoassay
nucleicacid
amplif
adapt
poc
scheme
principl
commonli
use
separ
concentr
cell
within
poc
devic
cell
size
label
fluoresc
magnet
electrophoret
mobil
cell
adhes
analysi
real
biolog
sampl
detect
highli
virul
pathogen
presum
abil
detect
cell
larg
sampl
volum
concurr
wash
sampl
contamin
eg
cell
order
prevent
instanc
downstream
pcr
inhibit
microchannel
clog
particular
environment
water
sampl
may
contain
certain
substanc
like
humic
acid
inhibit
pcr
reaction
abl
drastic
decreas
result
signal
presenc
contamin
biolog
sampl
may
particularli
troublesom
microfluid
assay
veterinari
applic
particular
advantag
bioanalysi
labonachip
devic
concern
process
pathogen
rna
owe
confin
environ
purif
step
requir
minim
user
handl
probabl
rna
contamin
degrad
ubiquit
rnase
highli
decreas
scheme
employ
nucleicacid
extract
deterg
rather
high
temperatureoper
lytic
enzym
coupl
isotherm
eg
lamp
instead
pcr
rtpcr
amplif
process
also
prefer
regard
way
concept
microfluid
might
abl
address
recurr
gap
veterinari
lack
inform
rna
qualiti
integr
complic
standard
rtpcr
procedur
sever
commerci
multiplex
poc
test
diagnosi
influenza
respiratori
virus
alreadi
avail
filmarray
rp
biofir
diagnost
salt
lake
cityut
unit
state
xtag
rvp
luminex
toronto
canada
xpert
flu
panel
cepheid
sunnyvaleca
unit
state
consist
close
system
includ
sampl
prepar
detect
integr
rtpcr
howev
system
may
abl
detect
low
viral
load
specimen
case
xpert
flu
panel
import
avian
influenza
virus
addit
econom
constraint
still
restrict
full
applic
test
poc
test
xpert
flu
panel
estim
cost
euro
per
test
compar
euro
antigen
test
current
labonachip
devic
despit
simpler
convent
laboratori
analyt
apparatu
still
requir
complex
somewhat
expens
fabric
procedur
onto
plastic
glass
substrat
thu
sever
limit
afford
avail
poor
countri
tabl
display
literatur
refer
proofofprincipl
scheme
poc
devic
detect
identif
pathogen
veterinari
import
emerg
topic
develop
new
bioanalyt
procedur
structur
system
nanotechnolog
particularli
gener
use
nanostructur
diagnost
applic
socal
field
nanobiotechnolog
novel
improv
electron
devic
biosensor
platform
emerg
consequ
inher
small
size
enlarg
surfac
area
unusu
optic
magnet
catalyt
mechan
properti
nanomateri
unlik
bulk
materi
depend
specif
natur
biosens
nanomateri
may
act
label
includ
signal
amplif
biomolecul
immobil
support
even
probe
specif
biotarget
anchor
certain
nanomateri
also
use
preconcentr
biolog
target
among
applic
label
commonli
employ
labelbas
detect
method
usual
timeconsum
labor
intens
labelfre
method
due
label
step
label
also
limit
shelf
live
subject
leakag
sens
surfac
howev
labelbas
method
usual
provid
superior
perform
especi
term
sensit
labelfre
one
moreov
standard
protocol
label
procedur
alreadi
avail
fluoresc
label
far
common
approach
regard
although
suffer
ph
sensit
photobleach
time
handicap
advent
nanoengin
propel
search
develop
new
improv
label
nanoparticl
np
wide
employ
type
nanomateri
biosens
especi
metal
np
metal
np
inorgan
np
exhibit
improv
physicochem
characterist
compar
fluoresc
label
includ
higher
sensit
gener
suitabl
construct
highdens
bioanalyt
devic
take
advantag
high
signaltonois
ratio
sn
easili
synthesiz
function
simpl
mix
room
temperatur
control
selfassembl
surfac
structur
gold
nanoparticl
gnp
particular
alreadi
use
frequent
molecular
diagnosi
advantag
includ
low
toxic
versatil
mani
specif
biorecognit
applic
scheme
one
common
way
enhanc
gnp
signal
even
thu
sensit
detect
inclus
final
step
silver
stain
silver
enhanc
yield
detect
scheme
abl
preclud
use
prior
pcr
amplif
step
high
sensit
exhibit
mani
npbase
detect
layout
especi
form
microarray
enabl
avoid
prior
step
nucleicacid
amplif
quantum
dot
qd
constitut
anoth
class
metal
np
abl
fluoresc
tag
much
brighter
photost
convent
organ
fluorophor
plu
color
directli
correl
size
exhibit
broad
excit
wavelength
window
narrow
emiss
wavelength
window
larg
stoke
shift
allow
excit
wavelength
far
remov
emiss
peak
sinc
qd
differ
emiss
peak
accord
differ
size
excit
use
singl
wavelength
excit
sourc
detect
multipl
target
complex
biolog
system
hallmark
np
anoth
altern
overlap
close
space
fluoresc
emiss
peak
consequ
limit
maximum
number
fluoresc
dye
discrimin
simultan
test
multipl
pathogen
singl
pcr
tube
use
masscod
tag
panel
distinct
label
differ
molecular
weight
initi
step
multiplex
rt
pcr
use
primer
label
masscod
tag
unincorpor
primer
remov
photocleav
tag
amplifi
primer
releas
uv
irradi
subsequ
mass
spectrometri
analysi
assign
identifi
tag
specif
pathogen
principl
multiplex
abil
limit
highest
primer
concentr
contain
pcr
mix
method
appli
identif
respiratori
pathogen
hemorrhag
virus
offer
rapid
specif
sensit
costcompetit
altern
convent
pcr
rtpcr
diseas
diagnosi
poc
devic
nevertheless
difficulti
persist
miniatur
mass
spectromet
devic
among
metal
np
also
magnet
np
mnp
equival
design
frequent
found
literatur
includ
magnet
nanobead
nanomagnet
nanomagnet
bead
nanomagnet
sphere
nanospher
vastli
employ
mani
biosensor
layout
diagnosi
despit
match
nanos
molecular
recognit
probe
target
microsc
counterpart
magnet
microparticl
frequent
prefer
magnet
label
biosens
view
easi
detect
lesser
abund
microbead
routin
optic
microscopi
magnet
detect
easi
purif
process
thu
allow
effici
remov
nonspecif
bound
label
enhanc
assay
perform
howev
higher
sv
nanobead
provid
much
bind
site
bioprob
biotarget
anchor
henc
higher
sn
often
magnet
particl
use
target
preconcentr
larg
initi
sampl
volum
purif
parallel
detect
step
carri
anoth
particl
work
label
eg
fluorophor
gnp
case
initi
captur
target
probefunction
magnet
particl
follow
releas
target
debind
final
detect
magnet
control
remov
nonspecif
bound
bead
magnet
wash
improv
sensit
achiev
upon
elimin
timeconsum
wash
step
nonspecif
bound
molecul
process
exampl
improv
significantli
detect
specif
genom
rna
sinc
rna
enrich
due
magnet
confin
also
preclud
effect
common
interf
substanc
common
rna
inhibitor
addit
use
magnet
bead
permit
test
optic
opaqu
sampl
case
mani
crude
biolog
sampl
magnet
particl
manipul
offchip
perman
magnet
make
easier
design
dispos
inexpens
test
moreov
magnet
interact
affect
surfac
charg
ph
ionic
strength
temperatur
thu
compat
biochem
process
unlik
inorgan
np
organ
np
enhanc
structur
flexibl
biocompat
biodegrad
liposom
constitut
attract
type
organ
np
effici
dnaprob
label
signal
amplif
commonli
achiev
fill
liposom
particl
dye
fluorophor
molecul
amplifi
respons
signal
abl
yield
quantit
result
anoth
way
use
liposom
biosens
conjunct
resist
techniqu
neg
charg
liposom
upon
bind
immobil
dna
chain
also
neg
form
giant
neg
charg
surfac
repel
target
dna
chain
lead
shift
electrochem
respons
last
year
chemistri
research
render
rang
new
structur
base
carbon
allotrop
promis
biosens
purpos
seem
carbon
nanotub
cnt
form
singl
swcnt
multiwal
cnt
mwcnt
depend
number
cylindr
layer
uniqu
electron
properti
enlarg
surfac
area
dna
immobil
also
possess
high
electr
conduct
similar
copper
much
higher
polym
physic
robust
chemic
inert
nanotub
may
act
individu
nanoelectrod
suffici
free
space
neighbor
nanotub
prevent
overlap
diffus
layer
therefor
yield
high
sn
valu
henc
improv
detect
limit
provid
high
sensit
amen
pcrfree
detect
product
sometim
unaccept
irreproduc
ultrasensit
detect
circumv
use
cheap
cnt
array
multipl
biolog
target
way
averag
differ
batch
recent
advanc
nucleicacid
synthesi
modif
process
discoveri
nucleic
acid
catalyt
regulatori
activ
prompt
develop
nanoengin
nucleicacid
analogu
new
improv
abil
biorecognit
diagnost
purpos
among
aptam
synthet
nucleic
acid
abl
interact
molecular
cellular
target
high
specif
sensit
abil
fold
mani
tertiari
conform
aptam
gener
systemat
evolut
ligand
exponenti
enrich
selex
combinatori
procedur
start
pool
candid
nucleicacid
molecul
gener
nucleicacid
librari
compar
antibodi
nucleicacid
synthes
reproduc
way
longer
shelf
live
revers
denatur
without
loss
activ
remark
characterist
probe
biosens
requir
prior
knowledg
molecular
differ
specif
target
nonspecif
one
shown
cancer
diagnosi
dna
sequenc
dna
librari
bind
cellsurfac
marker
cancer
cell
determin
comparison
bind
healthi
control
cell
addit
detect
occur
correspond
antibodi
cancer
produc
process
obvious
attract
applic
diagnosi
infecti
diseas
well
high
select
sensit
achiev
aptam
permit
elimin
sampl
pretreat
thu
promis
poc
applic
inabl
distinguish
fluoresc
signal
label
unlabel
probe
common
problem
microfluid
devic
sinc
label
probe
bind
target
wash
microchannel
differ
fluoresc
label
use
tag
probe
target
detect
proceed
via
fluoresc
reson
energi
transfer
fret
upon
occurr
bioaffin
reaction
howev
procedur
unpract
bioanalysi
owe
cumbersom
dual
label
procedur
case
dna
detect
circumv
use
molecular
beacon
mb
consid
particular
type
aptam
mb
singlestrand
oligonucleotid
hairpin
stemandloop
structur
label
fluorophor
one
extrem
chain
fluoresc
quencher
extrem
close
proxim
extrem
prevent
fluoresc
emiss
hybrid
event
occur
complimentari
chain
structur
becom
linear
henc
fluoresc
aris
way
target
label
unnecessari
anoth
type
synthet
nucleicacid
analogu
constitut
peptid
nucleic
acid
pna
sugarphosph
backbon
replac
peptid
structur
use
probe
nucleicacid
recognit
system
allow
select
sensit
hybrid
low
ionicstrength
media
high
thermal
stabil
electr
uncharg
pna
suitabl
promot
occurr
biochem
event
trigger
format
neg
charg
pnasinglestrand
dna
hybrid
ie
kind
onoff
process
biosens
scheme
report
literatur
employ
least
one
nanotechnologybas
structur
describ
depict
tabl
togeth
transduct
mechan
employ
perform
quantif
advanc
observ
past
decad
proteom
genom
led
discoveri
novel
diagnost
biomark
pathogen
relev
human
medicin
parallel
cuttingedg
develop
materi
scienc
nanotechnolog
also
regist
veterinari
scienc
practic
took
train
greatli
favor
advanc
microfluid
technolog
nanoengin
structur
especi
coupl
togeth
led
unpreced
degre
highthroughput
largescal
genet
analysi
even
wholegenom
level
ultim
highthroughput
multiplex
abil
vivo
implant
swallow
nanosensor
array
abl
monitor
anim
physiolog
health
statu
entir
lifetim
even
beyond
intend
track
assess
qualiti
anim
product
human
feed
way
current
shortcom
relat
limit
number
sanitari
surveil
resourc
alloc
guarante
proper
product
origin
stock
ship
could
circumv
far
poc
scheme
devic
reach
exquisit
sensit
threshold
requir
detect
nucleicacid
trace
unamplifi
biolog
sampl
ultim
goal
nucleicacid
test
human
diagnost
veterinari
medicin
practic
still
lack
commerci
avail
poc
devic
probabl
result
manufactur
commerci
costeffect
constraint
shortag
fundament
knowledg
remain
expens
singl
test
mani
test
target
poc
diagnosi
ultim
prove
costeffect
save
unnecessari
laboratori
manpow
taken
account
major
challeng
need
initi
invest
often
prohibit
small
compani
usual
difficulti
obtain
regulatori
approv
test
commerci
effect
improv
human
health
adequ
coordin
action
face
anim
diseas
need
especi
concern
livestock
includ
effect
technolog
transfer
develop
countri
diseas
preval
diseas
prevent
measur
may
crucial
avoid
contain
epidem
probabl
still
without
meritori
exampl
world
effect
commun
coordin
among
public
health
anim
health
wildlif
diseas
surveil
author
necessari
tackl
problem
pose
common
hazard
veterinari
diseas
especi
situat
outbreak
endang
anim
human
health
well
